Genesis Drug Discovery & Development (Gd3), A Member Of Genesis Global Group, Acquires Jss Medical Research To Expand Its Clinical Services Portfolio
Acquiring Company
Genesis Drug Discovery & Development
Acquired Company
JSS Medical Research
Description
Genesis Drug Discovery and Development (GD3), Contract Research Organization (CRO) arm and member of Genesis Global Group (GGG), announced today that it has acquired JSS Medical Research. With corporate headquarters in Montreal, Canada, and regional offices in Bogotá, Columbia, Faridabad, India, and Warsaw, Poland, JSS Medical Research provides pre- and post-approval clinical development services to support pharmaceutical, biotechnology, nutraceutical and medical device companies worldwide.
Quick answer
Genesis Drug Discovery & Development is acquiring JSS Medical Research, announced May 10, 2023.
- How much did Genesis Drug Discovery & Development pay for JSS Medical Research?
- The deal value was not disclosed.
- What does Genesis Drug Discovery & Development do?
- Genesis Drug Discovery & Development (GD3) is a fully integrated CRO providing services to support drug discovery programs of our clients from target discovery through IND filing and managing Phase I-IIII clinical..
Source: Fundz verified event record.
Other recent acquisitions in Pharmaceutical and Medical
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Vivo Infusion Acquires Specialty Infusion Centers (June 20, 2023)
- Lilly To Acquire Dice Therapeutics To Advance Innovation In Immunology (June 20, 2023)
- Abiogen Pharma Completes The Acquisition Of Effrx (May 29, 2023)
- Shockwave Medical Completes Acquisition Of Neovasc (April 11, 2023)
- Ironwood And Vectivbio Announce Expiration Of Hart-Scott-Rodino Waiting Period For Proposed Acquisition Of Vectivbio (June 16, 2023)
- Sunmed To Acquire Avanos Medical’S Respiratory Health Business (June 8, 2023)
Who to call at Genesis Drug Discovery & Development, and when
When Genesis Drug Discovery & Development changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Genesis Drug Discovery & Development raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Genesis Drug Discovery & Development, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Genesis Drug Discovery & Development. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Genesis Drug Discovery & Development makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired JSS Medical Research?
JSS Medical Research was acquired by Genesis Drug Discovery & Development. The deal was reported on May 10, 2023. Genesis Drug Discovery & Development is privately held and operates in Biotechnology.
When did Genesis Drug Discovery & Development acquire JSS Medical Research?
Genesis Drug Discovery & Development's acquisition of JSS Medical Research was reported on May 10, 2023. Genesis Drug Discovery and Development (GD3), Contract Research Organization (CRO) arm and member of Genesis Global Group (GGG), announced today that it has acquired JSS Medical Research. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does JSS Medical Research do?
JSS Medical Research is a full-service clinical research organization (CRO) with strong academic affiliations offering a wide range of services internationally. It is privately held, operating in Biotechnology.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.